Clinical trial
Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of…
NCT00120081 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00120081 |
|---|---|
| Title | Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection |
| Official title | Phase 1, Single-Center, Double-Blind, Placebo-Controlled, Randomized, Dose-Escalation Study to Compare the Safety, Tolerability, and Immunogenicity of Three Intramuscular Administrations of Na-ASP-2 Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | Bill and Melinda Gates Foundation |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hookworm Infection |
| Intervention type | Biological |
| Interventions | Na-ASP-2/Alhydrogel Hookworm Vaccine, Saline placebo |
| Enrollment | 36 |
| Start date | Apr 1, 2005 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Jul 15, 2005 |
| Last update posted | May 31, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: